Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02074384 · ClinicalTrials.gov registry record · NA
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT02074384 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 161 participants.
The verdict
NCT02074384, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
International Diabetes Center (IDC) proposes a preference and usability study of glucose data acquisition and reporting, evaluating streamlined standardized cloud-based glucose reporting including work flow as well as patient and clinician preference at Type 1 Diabetes (T1D) Exchange sites to enhance standard Ambulatory Glucose Profile (AGP) reporting. This phase 2 project assesses the efficacy of standardized glucose data report generation and preferred report presentation format; both are necessary to increase use of continuous glucose monitoring (CGM) data to improve care processes and outcomes for Type 1 diabetes.
Interventions
- DEVICE Continuous Glucose Monitor
- DEVICE Self Monitoring Blood Glucose
- OTHER Clinician
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02074384
The ClinicalTrials.gov registry entry for NCT02074384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Continuous Glucose Monitor is the first listed.
NCT02074384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02074384 about?
NCT02074384 is a clinical study titled "Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)". International Diabetes Center (IDC) proposes a preference and usability study of glucose data acquisition and reporting, evaluating streamlined standardized cloud-based glucose reporting including work flow as well as patient and clinician preference at Type 1 Diabetes (T1D) Exchange sites to enhanc...
What is the current status of trial NCT02074384?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2014-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02074384?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Self Monitoring Blood Glucose (DEVICE), Clinician (OTHER).
Who is sponsoring clinical trial NCT02074384?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.